Argos Therapeutics Reports Results of Interim Analysis of the ADAPT Trial and Announces Review of Strategic Alternatives

Ads

You May Also Like

Tobias Linebäck appointed to lead GHP International

GHP Specialty Care AB (publ) (GHP) has appointed the company’s CFO and Deputy CEO ...

Aduro Biotech Reports Third Quarter 2017 Financial Results

BERKELEY, Calif., Oct. 31, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today reported ...